by Caroline Fife, M.D. | Oct 4, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitute Arrests, CTP / Skin Substitutes
On September 18th, 2024, Erica Everhart and Zach Bredl posted an article on the Care Journey website about the impact of fraud and abuse in value-based care. Spending on CTPs/skin subs is not the only fraud problem faced by Accountable Care Organizations (ACOs),...
by Caroline Fife, M.D. | Oct 2, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitute Arrests, CTP / Skin Substitutes
I’ve discussed the fact that nearly everyone is being audited by Medicare on their charges for Cellular Tissue Products (CTP’s) / Skin Substitutes. Depending on the type of audit, a practitioner can have to pay back not only the money they received for the...
by Caroline Fife, M.D. | Sep 20, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
Some days ago, I asked if it was legal for practitioners to make large profits off the cost of CTPs/skin subs – and the answer seems to be “yes”. Of course, I knew that no reputable attorney was going to send me a considered legal opinion on social media. I am still...
by Caroline Fife, M.D. | Sep 18, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitute Arrests
Hi Dr. Fife, I’m sure you’re receiving plenty of feedback on this topic, but regarding your question about whether providers can receive discounts on ASP products, I’ve consistently been told the answer is yes… at least, I hope it’s yes—otherwise, we’re all in...
by Caroline Fife, M.D. | Sep 16, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes, Fight the Good Fight
Joe Rolly posted a fantastic article explaining the pathways by which various CTPs/skin subs come to market, and what that means in terms of the claims that sales representatives can make. Because amniotic products are the fastest growing sector of the market, I am...
by Caroline Fife, M.D. | Sep 13, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes, Fight the Good Fight
I am genuinely trying to understand what is “allowed” and what isn’t when it comes to CTPs/skin subs in the office-based and “mobile”. Everyone has heard about what happened to the owners of a CTP/skin sub company in Arizona. I am trying to understand the scenario...
by Caroline Fife, M.D. | Sep 10, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes, Fight the Good Fight
I am genuinely trying to understand what is “allowed” and what isn’t when it comes to Cellular Tissue Products (CTPs) / skin substitutes in the office-based setting – and that includes the “mobile” practice (which may include skilled nursing and care in the patient’s...
by Caroline Fife, M.D. | Sep 4, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
There’s a “problem” with the proposed LCD on CTPs/skin subs that no one is talking about. It’s a problem we’ve largely ignored for more than 20 years. To explain, I have to go back to 1998 when I was one of several sites for both the Apligraf and the Regranex clinical...
by Caroline Fife, M.D. | Aug 23, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitute Arrests, Skin Perfusion Pressure (SPP)
Last week I gave a talk at the Amputation Prevention Symposium entitled, “Elevate the CLI Patient’s Voice: Why it is so Important to do the Right Thing?” I have to confess that when the meeting organizers first asked me to explain why it’s important to do the...
by Caroline Fife, M.D. | Aug 14, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitute Arrests, CTP / Skin Substitutes
Susan Paquette, the VP of the Wound division of SmartTRAK, recently posted an article on that company’s blog about the Cellular Tissue Product (CTP) / skin substitute industry. SmartTRAK provides market intelligence on industry trends and has been closely watching the...
